Health Affairs October 30, 2025
Editor’s Note
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analyses of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress. Health Affairs Forefront alone reviews all submissions then selects, edits, and publishes them only if they meet Forefront’s editorial standards.
On October 16, 2025, President Trump announced three new actions to expand access to fertility care. First, several common fertility drugs will be available for direct purchase at a reduced price through TrumpRx.gov. Second, the Food and Drug Administration (FDA) will expedite its...
Today's Sponsors
Today's Sponsor